Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Dimethyl Fumarate × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

Cisplatin 1503 Carboplatin 1407 Cyclophosphamide 1354 Gemcitabine 1227 Bevacizumab 1218 Paclitaxel 1207 Radiotherapy 1164 Docetaxel 1076 pembrolizumab 1022 Oxaliplatin 924 Capecitabine 891 Fluorouracil 828 Rituximab 726 Doxorubicin 681 Nivolumab 675 Dexamethasone 663 Etoposide 656 Irinotecan 622 Leucovorin 569 Pemetrexed 505 Drug Therapy 483 Cetuximab 479 Cytarabine 465 Trastuzumab 464 Magnetic Resonance Spectroscopy 449 Filgrastim 446 Prednisone 432 Lenalidomide 407 Temozolomide 401 Vincristine 397

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02546440 2023-03-31

DMF-CTCL

Universitätsmedizin Mannheim

Phase 2 Completed

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡